Resmed Inc. Announces Results for the First Quarter of Fiscal Year 2027
Revenue$1.4 billion+6% YoY
EPS$2.92
Collected automatically from companies' SEC filings (Form 8-K, Item 2.02)
Forensic equity research on US stocks. No spam, unsubscribe anytime.